Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: The Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repair

European Journal of Neuroscience

Volumn 37, Issue 10, 2013, Pages 1550-1563

  Marchetti, Bianca ^a,b   L'Episcopo, Francesca ^a,b   Morale, Maria Concetta ^b   Tirolo, Cataldo ^b   Testa, Nuccio ^b   Caniglia, Salvo ^b   Serapide, Maria Francesca ^a   Pluchino, Stefano ^c  

^a UNIVERSITY OF CATANIA   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dopaminergic neurons; Neurodegeneration; Neurogenesis; Neuroprotection Parkinson's disease; Reactive astrocytes

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BETA CATENIN; WNT PROTEIN; WNT1 PROTEIN;

ARTICLE; ASTROCYTE; BRAIN INJURY; CELL INTERACTION; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MICROGLIA; NERVE CELL PLASTICITY; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; MICE; MPTP POISONING; NEURONS; WNT SIGNALING PATHWAY;

EID: 84878011253     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12166     Document Type: Article

References (167)

1. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804.
2. Abou-Sleiman, P.M., Muqit, M.M. & Wood, N.W. (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci., 7, 207-219.
3. Adachi, K., Mirzadeh, Z., Sakaguchi, M., Yamashita, T., Nikolcheva, T., Gotoh, Y., Peltz, G., Gong, L., Kawase, T., Alvarez-Buylla, A., Okano, H. & Sawamoto, K. (2007) β-Catenin signaling promotes proliferation of progenitor cells in the adult mouse subventricular zone. Stem Cells, 25, 2827-2836.
4. Alvarez-Builla, A., Garcia-Verdugo, J.M. & Tramontin, A.D. (2001) A unified hypothesis on the lineage of neural stem cells. Nat. Rev. Neurosci., 2, 2287-2293.
5. van Amerongen, R. (2012) Alternative wnt pathways and receptors. Cold Spring Harb. Perspect. Biol., 4, pii: a007914.
6. van Amerongen, R., Mikels, A. & Nusse, R. (2008) Alternative wnt signaling is initiated by distinct receptors. Sci. Signal., 1, re9.
7. Angers, S. & Moon, R.T. (2009) Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol., 10, 468-477.
8. Baker, S.A., Baker, K.A. & Hagg, T. (2004) Dopaminergic nigrostriatal projections regulate neural precursor cell proliferation in the adult mouse subventricular zone. Eur. J. Neurosci., 20, 575-579.
9. Barkho, B.Z., Song, H., Aimone, J.B., Smrt, R.D., Kuwabara, T., Nakashima, K., Gage, F.H. & Zhao, X. (2006) Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev., 15, 407-421.
10. Berwick, D.C. & Harvey, K. (2012a) LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6. Hum. Mol. Genet., 21, 4966-4979.
11. Berwick, D.C. & Harvey, K. (2012b) The importance of Wnt signalling for neurodegeneration in Parkinson's disease. Biochem. Soc. T., 40, 1123-1128.
12. Bezard, E. & Gross, C.E. (1998) Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach. Prog. Neurobiol., 55, 93-116.
13. Blackburn, D., Sargsyan, S., Monk, P.N. & Shaw, P.J. (2009) Astrocyte function in motor neuron disease: a future therapeutic target? Glia, 57, 1251-1264.
14. Borta, A. & Holinger, G.U. (2007) Dopamine and adult neurogenesis. J. Neurochem., 100, 587-595.
15. Butovsky, O., Ziv, Y., Schwartz, A., Gennady, L., Talpalar, A.E., Pluchino, S., Martino, G. & Schwartz, M. (2006) Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci., 31, 149-160.
16. Cahoy, J.D., Emery, B., Kaushal, A., Foo, L.C., Zamanian, J.L., Christopherson, K.S., Xing, Y., Lubischer, J.L., Krieg, P.A., Krupenko, S.A., Thompson, W.J. & Barres, B.A. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci., 28, 264-278.
17. Cantuti-Castelvetri, I., Keller-Mccgandy, C., Bouziou, B., Asteris, G., Clark, T.W., Frosh, M.P. & Standaert, D.G. (2007) Effects of gender on nigral gene expression and parkinson disease. Neurobiol. Dis., 26, 606-614.
18. Castelo-Branco, G., Wagner, J., Rodriguez, F.J., Kele, J., Sousa, K., Rawal, N., Pasolli, H.A., Fuchs, E., Kitajewski, J. & Arenas, E. (2003) Differential regulation of midbrain dopaminergic neuron development by Wnt1, Wnt3a, and Wnt5a. Proc. Natl. Acad. Sci. USA, 100, 12747-12752.
19. Castelo-Branco, G., Rawal, N. & Arenas, E. (2004) GSK-3β inhibition/β-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J. Cell Sci., 117, 5731-5737.
20. Castelo-Branco, G., Sousa, K.M., Bryja, V., Pinto, L., Wagner, J. & Arenas, E. (2006) Ventral midbrain glia express region-specific transcription factors and regulate dopaminergic neurogenesis through Wnt-5a secretion. Mol. Cell. Neurosci., 31, 251-262.
21. Castelo-Branco, G., Andersson, E.R., Minina, E., Sousa, K.M., Ribeiro, D., Kokubu, C., Imai, K., Prakash, N., Wurst, W. & Arenas, E. (2010) Delayed dopaminergic neuron differentiation in Lrp6 mutant mice. Dev. Dynam., 239, 211-221.
22. Chacón, M.A., Varela-Nallar, L. & Inestrosa, N.C. (2008) Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Abeta oligomers. J. Cell. Physiol., 217, 215-227.
23. Chen, G., Bower, K.A., Ma, C., Fang, S., Thiele, C.J. & Luo, J. (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J., 18, 1162-1164.
24. Chen, H., Jacobs, E., Schwarzschild, M.A., McCullough, M.L., Calle, E.E., Thun, M.J. & Ascherio, A. (2005) Non steroidal anti-inflammatory drugs and the risk of Parkinson's disease. Ann. Neurol., 58, 963-967.
25. Chen, P.C., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W. & Johnson, J.A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. USA, 106, 2933-2938.
26. Chong, Z.Z. & Maiese, K. (2007) Cellular demise and inflammatory microglial activation during beta-amyloid toxicity are governed by Wnt1 and canonical signalling pathways. Cell. Signal., 19, 1150-1162.
27. Ciani, L. & Salinas, P.C. (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat. Rev. Neurosci., 6, 351-362.
28. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
29. Clevers, H. & Nusse, R. (2012) Wnt/beta-catenin signaling and disease. Cell, 149, 1192-1205.
30. Cunningham, C., Wilcockson, D.C., Campion, S., Lunnon, K. & Perry, V.H. (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci., 25, 9275-9284.
31. Curtis, M.A., Faull, R.L.M. & Eriksson, P.S. (2007) The effect of neurodegenerative diseases on the subventricular zone. Nat. Rev. Neurosci., 8, 712-723.
32. Curtis, M.A., Low, F.L. & Faull, R.L.M. (2012) Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation. Dev. Neurobiol., 72, 990-1005.
33. Cusimano, M., Biziato, D., Brambilla, E., Donegà, M., Alfaro-Cervello, C., Snider, S., Salani, G., Pucci, F., Comi, G., Garcia-Verdugo, J.M., De Palma, M., Martino, G. & Pluchino, S. (2012) Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain, 135, 447-460.
34. De Ferrari, G.F., Chacon, M.A., Barria, M.I., Garrido, J.L., Godoy, J.A., Olivares, G., Reyes, A.E., Alvarez, A., Bronfman, M. & Inestrosa, N.C. (2003) Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils. Mol. Psychiatr., 8, 195-208.
35. Depboylu, C., Stricker, S., Ghobril, J.P., Oertel, W.H., Priller, J. & Höglinger, G.U. (2012) Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp. Neurol., 238, 183-191.
36. Di Monte, D.A. & Langston, J.W. (1995) Idiopathic and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced Parkinsonism. In Kettenmann, H. & Ransom, B.R. (Eds), Neuroglia. Oxford University Press, NY, pp. 997-1019.
37. Duka, T., Duka, V., Joyce, J.N. & Sidhu, A. (2009) α-Synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J., 23, 2820-2830.
38. Ekdahl, C.T. (2012) Microglial activation: tuning and pruning adult neurogenesis. Front. Pharmacol., 3, 41.
39. Ekdahl, C.T., Kokaia, Z. & Lindvall, O. (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience, 158, 1021-1029.
40. Engele, J. & Bohn, M.C. (1991) The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci., 11, 3070-3078.
41. Frank-Cannon, T.C., Tran, T., Ruhn, K.A., Martinez, T.N., Hong, J., Marvin, M., Hartley, M., Trevino, I., O'Brien, D.E. & Casey, B. (2008) Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci., 28, 10825-10834.
42. Freundlieb, N., François, C., Tandé, D., Ortel, W.H., Hirsh, E.C. & Hoglinger, G.U. (2006) Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J. Neurosci., 26, 2321-2325.
43. Gallo, F., Morale, M.C., Avola, R. & Marchetti, B. (1995) Cross-talk between luteinizing hormone-releasing hormone (LHRH) neurons and astroglial cells: developing glia release factors that accelerate neuronal differentiation and stimulate LHRH release from GT(1-1) neuronal cell line and LHRH neurons induce astroglia proliferation. Endocrine, 3, 863-874.
44. Gallo, F., Morale, M.C., Spina-Purrello, V., Tirolo, C., Testa, N., Farinella, Z., Avola, R., Beaudet, A. & Marchetti, B. (2000) Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture. Synapse, 36, 233-253.
45. Gao, H.M. & Hong, J.S. (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol., 29, 357-365.
46. Gao, H.M., Liu, B., Zhang, W. & Hong, J.S. (2003) Critical role of microglia NADPH-oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J., 17, 1954-1966.
47. Gao, H.M., Kotzbauer, P.T., Kunihiro, U., Leight, S., Trojanowsski, J.Q. & Lee, V.M.-Y. (2008) Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration. J. Neurosci., 28, 7687-7698.
48. Gennuso, F., Fernetti, C., Tirolo, C., Testa, N., L'Episcopo, F., Caniglia, S., Morale, M.C., Ostrow, J.D., Pascolo, L., Tiribelli, C. & Marchetti, B. (2004) Bilirubin protects astrocytes from its own toxicity inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp 1). Proc. Natl. Acad. Sci. USA, 101, 2470-2475.
49. Gillardon, F., Schmid, R. & Draheim, H. (2012) Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience, 208, 41-48.
50. Glinka, A., Dolde, C., Kirsch, N., Huang, Y.L., Kazanskaya, O., Ingelfinger, D., Boutros, M., Cruciat, C.M. & Niehrs, C. (2011) LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling. EMBO Rep., 12, 1055-1061.
51. Gordon, M.D. & Nusse, R. (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J. Biol. Chem., 281, 22429-22433.
52. Harrison-Uy, S.J. & Pleasure, S.J. (2012) Wnt signaling and forebrain development. Cold Spring Harb. Perspect. Biol., 4, a008094.
53. He, P. & Shen, Y. (2009) Interruption of β-catenin signaling reduces neurogenesis in Alzheimer's disease. J. Neurosci., 29, 6545-6557.
54. He, X.J., Nakayama, H., Dong, M., Yamauchi, H., Ueno, M., Uetsuka, K. & Doi, K. (2006) Evidence of apoptosis in the subventricular zone and rostral migratory stream in the MPTP mouse model of Parkinson disease. J. Neuropath. Exp. Neur., 65, 873-882.
55. Healy, D.G., Falchi, M., O'Sullivan, S.S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C.P., Goldwurm, S., Ferreira, J.J., Tolosa, E., Kay, D.M., Klein, C., Williams, D.R., Marras, C., Lang, A.E., Wszolek, Z.K., Berciano, J., Schapira, A.H., Lynch, T., Bhatia, K.P., Gasser, T., Lees, A.J. & Wood, N.W. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol., 7, 583-590.
56. Hermann, A. & Storch, A. (2008) Endogenous regeneration in Parkinson's disease: do we need orthotopic dopaminergic neurogenesis? Stem Cells, 26, 2749-2752.
57. Hermann, A., Maisel, M., Wegner, F., Liebau, S., Kim, D.W. & Gerlach, M. (2006) Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells, 24, 949-964.
58. Hermann, A., Suess, C., Fauser, M., Kanzler, S., Witt, M., Fabel, K., Schwarz, J., Höglinger, G.U. & Storch, A. (2009) Rostro-caudal loss of cellular diversity within the periventricular regions of the ventricular system. Stem Cells, 27, 928-941.
59. Hirsch, E.C. & Hunot, S. (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol., 8, 382-397.
60. Ho, A. & Blum, M. (1998) Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J. Neurosci., 18, 5614-5629.
61. Hoang, T., Choi, D.K., Nagai, M., Wu, D.C., Nagata, T., Prou, D., Wilson, G.L., Vila, M., Jackson-Lewis, V., Dawson, V.L., Dawson, T.M., Chesselet, M.F. & Przedborski, S. (2009) Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radical Bio. Med., 47, 1049-1056.
62. Hoglinger, G.U., Rizk, P., Muriel, M.P., Duyckaerts, C., Oertel, W.H., Caille, I. & Hirsch, E. (2004) Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci., 7, 726-735.
63. Hoglinger, G.U., Barker, R.A., Hagg, T., Arias-Carrion, O., Caldwell, M.A. & Hirsch, E.C. (2012) Quantitative evaluation of the human subventricular zone. Brain, e222, 1-6.
64. Horner, P.J. & Palmer, T.D. (2003) New roles for astrocytes: the night life of an 'astrocyte'. La vida loca!. Trends Neurosci., 26, 597-603.
65. Hornykiewicz, O. (1993) Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv. Neurol., 60, 140-147.
66. Hu, X., Zhang, D., Pang, H., Caudle, W.M., Li, Y., Gao, H., Liu, Y., Qian, L., Wilson, B., Di Monte, D.A., Ali, S.F., Zhang, J., Block, M.L. & Hong, J.S. (2008) Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J. Immunol., 181, 7194-7204.
67. Inestrosa, N.C. & Arenas, E. (2010) Emerging role of Wnts in the adult nervous system. Nat. Rev. Neurosci., 11, 77-86.
68. Inestrosa, N.C. & Toledo, E.M. (2008) The role of Wnt signalling in neuronal dysfunction in Alzheimer's disease. Mol. Neurodegener., 3, 9.
69. Jackson-Lewis, V. & Przedborski, S. (2007) Protocol for the MPTP model of Parkinson's disease. Nat. Protoc., 2, 141-151.
70. Janda, C.Y., Waghray, D., Levin, A.M., Thomas, C. & Garcia, K.C. (2012) Structural basis of Wnt recognition by Frizzled. Science, 337, 59-64.
71. Jiao, J. & Chen, D.F. (2008) Induction of neurogenesis in nonconventional neurogenic regions of the adult central nervous system by niche astrocyte-produced signals. Stem Cells, 26, 1221-1230.
72. Joksimovic, M., Yun, B.A., Kittappa, R., Anderegg, A.M., Chang, W.W., Taketo, M.M., McKay, R.D. & Awatramani, R.B. (2009) Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis. Nat. Neurosci., 12, 125-131.
73. Jope, R.S., Yuskaitis, C.J. & Beurel, E. (2007) Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res., 32, 577-595.
74. Kalani, M.Y.S., Cheshir, S.H., Cord, B.J., Bababeygy, S.R., Vogel, H., Weissman, I.L., Palmer, T.D. & Nusse, R. (2008) Wnt-mediated self-renewal of neural stem/progenitor cells. Proc. Natl. Acad. Sci. USA, 105, 16970-16975.
75. Kazanis, I. (2009) The subependymal zone neurogenic niche: a beating heart in the centre of the brain: how plastic is adult neurogenesis? Opportunities for therapy and questions to be addressed. Brain, 132, 2909-2921.
76. Kele, J., Andersson, E.R., Villaescusa, J.C., Cajanek, L., Parish, C.L., Bonilla, S., Toledo, E.M., Bryja, V., Rubin, J.S., Shimono, A. & Arenas, E. (2012) SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells. Stem Cells, 30, 865-875.
77. Kim, B., Yang, M.S., Choi, D., Kim, J.H., Kim, H.S., Seol, W., Choi, S., Jou, I., Kim, E.Y. & Joe, E.H. (2012) Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia. PLoS ONE, 7, e34693.
78. Kim, H., Won, S., Hwang, D.Y., Lee, J.S., Kim, M., Kim, R., Kim, W., Cha, B., Kim, T., Kim, D., Costantini, F. & Jho, E.H. (2011) Downregulation of Wnt/β-catenin signalling causes degeneration of hippocampal neurons in vivo. Neurobiol. Aging, 32, 2316.e1-2316.e15.
79. Kitagua, H., Ray, W.J., Glantsching, H., Nantermet, P.V., Yu, Y., Leu, C.T., Harada, S., Kato, S. & Freedman, L.P. (2007) A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signalling. Mol. Cell. Biol., 27, 7486-7496.
80. Kuwabara, T., Hsieh, J., Muotri, A., Yeo, G., Warashira, M., Lie, D.C., Moore, L., Nakashima, K., Asashima, M. & Gage, F.H. (2009) Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat. Neurosci., 12, 1097-1105.
81. Kwok, J.B., Hallupp, M., Loy, C.T., Chan, D.K., Woo, J., Mellick, G.D., Buchanan, D.D., Silburn, P.A., Halliday, G.M. & Schofield, P.R. (2005) GSK3β polymorphism alter transcription and splicing in Parkinson's disease. Ann. Neurol., 58, 829-839.
82. Langston, J.W. (2006) The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann. Neurol., 59, 591-596.
83. Langston, J.W., Forno, L.S., Tetrud, J., Reevers, A.G., Kaplan, J.A. & Karluk, D. (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine exposure. Ann. Neurol., 46, 598-605.
84. Lei, Z.N.L., Zhang, L.M. & Sun, F.Y. (2008) β-Catenin siRNA inhibits ischemia-induced striatal neurogenesis in adult rat brain following a transient middle cerebral artery occlusion. Neurosci. Lett., 435, 108-112.
85. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C. & Marchetti, B. (2010a) Glia as a turning point in the therapeutic strategy of Parkinson's disease. CNS Neurol. Disord-Dr., 9, 349-372.
86. L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Serra, P.A., Impagnatiello, F., Morale, M.C. & Marchetti, B. (2010b) Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. J. Neuroinflamm., 7, 83.
87. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Cossetti, C., D'Adamo, P., Zardini, E., Andreoni, L., Ihekwaba, A.E., Serra, P.A., Franciotta, D., Martino, G., Pluchino, S. & Marchetti, B. (2011a) Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. Neurobiol. Dis., 41, 508-527.
88. L'Episcopo, F., Serapide, M.F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Pluchino, S. & Marchetti, B. (2011b) A Wnt1 regulated Frizzled-1/β-catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol. Neurodegener., 13, 6-49.
89. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Impagnatiello, F. & Marchetti, B. (2011c) Switching the microglial harmful phenotype promotes lifelong restoration of substantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice. Rejuv. Res., 14, 411-424.
90. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Serapide, M.F., Deleidi, M., Pluchino, S. & Marchetti, B. (2012a) Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine) mouse model of Parkinson's disease involves crosstalk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. J. Neurosci., 32, 2062-2085.
91. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C. & Marchetti, B. (2012b). Rejuvenated astrocytes and canonical Wnt signaling rescue midbrain stem/neuroprogenitors in ageing mouse model of Parkinson's disease. Annual Meeting 'Neuroscience 2012', 13-17 October, New Orleans, Abstract 2012-S-2668-SfN.
92. L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M.C., Impagnatiello, F., Pluchino, S. & Marchetti, B. (2013) Aging-induced Nrf2-ARE pathway disruption in the subventricular zone (SVZ) drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation. J. Neurosci., 33, 1462-1485.
93. Li, H.L., Wang, L.L., Liu, S.J., Deng, Y.Q., Zhang, Y.J., Tian, Y.J., Wang, X.C., Chen, X.Q., Yang, Y., Zhang, J.Y., Wang, Q., Xu, H., Liao, F.F. & Wang, J.Z. (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's degeneration. Proc. Natl. Acad. Sci. USA, 104, 3591-3596.
94. Lie, D.C., Colamarino, S.A., Song, H.G., Désiré, L., Mira, H., Consiglio, A., Lein, E.S., Jessberger, S., Lansford, H., Diarie, A.R. & Gage, F.H. (2005) Wnt signaling regulates adult hippocampal neurogenesis. Nature, 473, 1370-1375.
95. Lim, D.A. & Alvarez-Buylla, A. (1999) Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc. Natl. Acad. Sci. USA, 96, 7526-7531.
96. Maiese, K., Faqi, L., Chong, Z.Z. & Chen, S.Y. (2008) The Wnt signalling pathway: aging gracefully as a protectionist? Pharmacol. Therapeut., 118, 58-81.
97. Maiese, K., Chong, Z.Z., Shang, Y.C. & Wang, S. (2012) Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin. Ther. Tar., 16, 1203-1214.
98. Marchetti, B. (2007) Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: key role of neuron-glia crosstalk. In Giovanni, G.D. & Esposito, E. (Eds), The Basal Ganglia Pathology: Recent Advances. Transworld Research Network, Kerala, India, pp. 225-252.
99. Marchetti, B. & Abbracchio, M.P. (2005) To be or not to be (inflamed): is that the question in anti-inflammatory drug therapy of neurodegenerative diseases? Trends Pharmacol. Sci., 26, 517-525.
100. Marchetti, B. & Pluchino, S. (2013) Wnt your brain be inflamed? Yes it Wnt! Trends Mol. Med., doi: 10.1016/j.molmed.2012.12.001. [Epub ahead of print].
101. Marchetti, B., Kettenmann, H. & Streit, W.J. (2005a) Glia-neuron crosstalk in neuroinflammation, neurodegeneration and neuroprotection. Brain Res. Rev., 48, 129-132.
102. Marchetti, B., Serra, P.A., L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Cioni, S., Gennuso, F., Rocchitta, G., Desole, M.S., Mazzarino, M.C., Miele, E. & Morale, M.C. (2005b) Hormones are key actors in gene × environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway. Ann. NY Acad. Sci., 1057, 296-318.
103. Marchetti, B., Serra, P.A., Tirolo, C., L'Episcopo, F., Caniglia, S., Gennuso, F., Testa, N., Miele, E., Desole, S., Barden, N. & Morale, M.C. (2005c) Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental Parkinsonism: pivotal role for glia-neuron interactions. Brain Res. Rev., 48, 302-321.
104. Marchetti, B., L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S. & Morale, M.C. (2011) Vulnerability to Parkinson's disease: towards a unifying theory of disease etiology. In Nriagu, J.O. (Ed.), Encyclopedia of Environmental Health. Elsevier Science, London, pp. 690-704.
105. Marchetti, B., Serapide, M.F., L'Episcopo, F., Tirolo, C., Testa, N., Caniglia, S. & Morale, M.C. (2012). Wnt/β-catenin signaling controls the vulnerability of midbrain dopaminergic neurons and spontaneous degeneration in aged mice: critical role of astrocyte-neuron crosstalk. Annual Meeting 'Neuroscience 2012', 13-17 October, New Orleans, USA, Abstract 2012-S-4124-SFN.
106. Martino, G., Pluchino, S., Bonfanti, L. & Schwartz, M. (2011) Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol. Rev., 91, 1281-1304.
107. McGeer, P.L. & McGeer, E.G. (2008) Glial reactions in Parkinson's disease. Movement Disord., 23, 474-483.
108. McGeer, P.L., Itagaki, S., Boyes, B.E. & McGeer, E.G. (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology, 38, 1285-1291.
109. McNaught, K.S.P. & Jenner, P. (1999) Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures. J. Neurochem., 73, 2469-2476.
110. Miller, K.R. & Streit, W.J. (2007) The effect of aging, injury and disease on microglial function: a case for cellular senescence. Neuron Glia Biol., 3, 245-253.
111. Morale, M.C., Serra, P., Delogu, M.R., Migheli, R., Rocchitta, G., Tirolo, C., Caniglia, S., Testa, N., L'Episcopo, F., Gennuso, F., Scoto, G.M., Barden, N., Miele, E., Desole, M.S. & Marchetti, B. (2004) Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide. FASEB J., 18, 164-166.
112. Morale, M.C., Serra, P.A., L'Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Gennuso, F., Giaquinta, G., Rocchitta, G., Desole, M.S., Miele, E. & Marchetti, B. (2006) Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience, 138, 869-878.
113. Morale, M.C., L'Episcopo, F., Tirolo, C., Giaquinta, G., Caniglia, S., Testa, N., Arcieri, P., Serra, P.A., Lupo, G., Alberghina, M., Harada, N., Honda, S., Panzica, G.C. & Marchetti, B. (2008) Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease? Brain Res. Rev., 57, 431-443.
114. Nair, V.D. & Olanow, C.W. (2008) Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signalling responses. J. Biol. Chem., 283, 15469-15478.
115. Njie, E.G., Boelen, E., Stassen, F.R., Steinbusch, H.W., Borchelt, D.R. & Streit, W.J. (2012) Ex vivo cultures of microglia from young and agent rodent brain reveal age-related changes in microglial function. Neurobiol. Aging, 33, 195e1-195e12.
116. Ohnuki, T., Nakamura, A., Okuyama, S. & Nakamura, S. (2010) Gene expression profiling reveals molecular pathways associated with sporadic Parkinson's disease. Brain Res., 1346, 26-42.
117. O'Keeffe, G.O., Tyers, P., Aarsland, D., Dalley, J.W., Barker, R.A. & Caldwell, M.A. (2009) Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc. Natl. Acad. Sci. USA, 106, 8754-8759.
118. Olanow, C.W., Shapira, A.H.V. & Agid, Y. (2003) Neurodegeneration and prospects for neuroprotection and rescue in Parkinson's disease. Ann. Neurol., 53, Suppl 3.
119. Osakada, F., Ooto, S., Akagi, T., Mandai, M., Akaike, A. & Takahashi, M. (2007) Wnt signalling promotes regeneration in the retina of adult mammals. J. Neurosci., 27, 4210-4219.
120. Ourednik, V.C., Ourednik, J., Xu, Y., Zhang, Y., Lynch, W.P., Snyder, E.Y. & Schachner, M. (2009) Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule. Stem Cells, 27, 2846-2856.
121. Papanikolaou, T., Lennington, J.B., Betz, A., Figueiredo, C., Salomone, J.D. & Conover, J.C. (2008) In vitro generation of dopaminergic neurons from adult subventricular zone neural progenitor cells. Stem Cells Dev., 17, 157-172.
122. Patapoutian, A. & Reichardt, L.F. (2000) Roles of Wnt proteins in neural development and maintenance. Curr. Opin. Neurobiol., 10, 392-399.
123. Petit-Paitel, A., Brau, F., Cazareth, J. & Chabry, J. (2009) Involvement of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/Mpp+-treated neurons. PLoS ONE, 4, e5491.
124. Pluchino, S., Quattrini, A., Brambilla, E., Gritti, A., Salani, G., Dina, G., Galli, R., Del Carro, U., Amadio, S., Bergami, A., Furlan, R., Comi, G., Vescovi, A.L. & Martino, G. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature, 422, 688-694.
125. Pluchino, S., Canotti, L., Rossi, B., Brambilla, E., Ottoboni, L., Salani, G., Martinello, M., Cattalini, A., Bergami, A., Furlan, R., Comi, G., Constantin, G. & Martino, G. (2005) Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature, 436, 266-271.
126. Pluchino, S., Muzio, L., Imitola, J., Deleidi, M., Alfaro-Cervello, C., Salani, G., Porcheri, C., Brambilla, E., Cavasinni, F., Bergamaschi, A., Garcia-Verdugo, J.M., Comi, G., Khoury, S.J. & Martino, G. (2008) Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain, 131, 2564-2578.
127. Pott Godoy, M.C., Tarelli, R., Ferrari, C.C., Sarchi, M.I. & Pitossi, F.J. (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain, 131, 1880-1894.
128. Prakash, N. & Wurst, W. (2006) Genetic networks controlling the development of midbrain dopaminergic neurons. J. Physiol., 575, 403-410.
129. Przedborski, S. (2010) Inflammation and Parkinson's disease pathogenesis. Movement Disord., 25, S55-S57.
130. Purro, S.A., Dickins, E.M. & Salinas, P.C. (2012) The secreted Wnt antagonist Dickkopf-1 is required for amyloid beta-mediated synaptic loss. J. Neurosci., 32, 3492-3498.
131. Rawal, N., Castelo-Branco, G., Souse, K.M., Kele, J., Kobayashy, K., Okano, H. & Arenas, E. (2006) Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. Exp. Cell Res., 312, 1626-1636.
132. Rawal, N., Corti, O., Sacchetti, P., Ardilla-Osorio, H., Sehat, B., Brice, A. & Arenas, E. (2009) Parkin protects dopaminergic neurons from excessive Wnt/β-catenin signalling. Biochem. Bioph. Res. Co., 388, 473-478.
133. Ribeiro, D., Laguna Goya, R., Ravindran, G., Vuono, R., Parish, C.L., Foldi, C., Piroth, T., Yang, S., Parmar, M., Nikkhah, G., Hjerling-Leffler, J., Lindvall, O., Barker, R.A. & Arenas, E. (2012) Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens. Neurobiol. Dis., 49C, 118-127.
134. Ricaurte, G.A., Irwin, I., Forno, L.S., DeLanney, L.E., Langston, E. & Langston, J.W. (1987) Aging and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain Res., 403, 43-51.
135. Rueger, M.A., Muesken, S., Walberer, M., Jantzen, S.U., Schnakenburg, K., Backes, H., Graf, R., Neumaier, B., Hoehn, M., Fink, G.R. & Schroeter, M. (2012) Effects of minocycline on endogenous neural stem cells after experimental stroke. Neuroscience, 215, 174-183.
136. Sakata, H., Niizuma, K., Yoshioka, H., Kim, G.S., Jung, J.E., Katsu, M., Narasimhan, P., Maier, C.M., Nishiyama, Y. & Chan, P.H. (2012) Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J. Neurosci., 32, 3462-3473.
137. Salinas, P.C. (2012) Wnt signaling in the vertebrate central nervous system: from axon guidance to synaptic function. Cold Spring Harb. Perspect. Biol., 4, pii: a008003.
138. Sandhu, J.K., Gardaneh, M., Iwasiow, R., Lanthier, P., Gangaraju, S., Ribecco-Lutkiewicz, M., Tremblay, R., Kiuchi, K. & Sikorska, M. (2009) Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiol. Dis., 33, 405-414.
139. Schwartz, M., London, A. & Shecter, R. (2009) Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity. Neuroscience, 158, 1133-1142.
140. Shibui, Y., He, X.J., Uchida, K. & Nakayama, H. (2009) MPTP-induced neuroblast apoptosis in the subventricular zone is not regulated by dopamine or other monoamine transporters. Neurotoxicology, 30, 1036-1044.
141. Shruster, A., Eldar-Finkelman, H., Melamed, E. & Offen, D. (2011) Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid β-peptide. J. Neurochem., 116, 522-529.
142. Shruster, A., Ben-Zur, T., Melamed, E. & Offen, D. (2012) Wnt signaling enhances neurogenesis and improves neurological function after focal ischemic injury. PLoS ONE, 7, e40843.
143. Sirerol-Piquer, M., Gomez-Ramos, P., Hernández, F., Perez, M., Morán, M.A., Fuster-Matanzo, A., Lucas, J.J., Avila, J. & García-Verdugo, J.M. (2011) GSK3β overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus. Hippocampus, 21, 910-922.
144. Sleiman, P.M., Healy, D.G., Mugit, M.M., Yang, Y.X., Van Der Brug, M., Holton, J.L., Revesz, T., Quinn, N.P., Bhatia, K., Diss, J.K., Less, A.J., Cookson, M.R., Latchman, D.S. & Wood, N.W. (2009) Characterization of a novel NR4A2 mutation in Parkinson's disease. Neurosci. Lett., 457, 75-79.
145. Sofroniew, M. & Vinters, H.B. (2010) Astrocytes: biology and pathology. Acta Neuropathol., 119, 7-35.
146. Song, H., Stevens, C.F. & Gage, F.H. (2002) Astroglia induce neurogenesis from adult neural stem cells. Nature, 417, 39-44.
147. Streit, W.J. (2010) Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history. Front. Aging Neurosci., 3, 2-22.
148. Takeshima, T., Johnston, J.M. & Commissiong, J.W. (1994) Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J. Neurosci., 14, 4769-4779.
149. Tang, M., Miyamoto, Y. & Huang, E.J. (2009) Multiple roles of β-catenin in controlling the neurogenic niche for midbrain dopamine neurons. Development, 136, 2027-2038.
150. Tang, M., Villaescusa, J.C., Luo, S.X., Guitarte, C., Lei, S., Miyamoto, Y., Takedo, M.M., Arenas, E. & Huang, E.J. (2010) Interactions of Wnt/beta-catenin signaling and sonic hedgehog regulate the neurogenesis of ventral midbrain dopamine neurons. J. Neurosci., 7, 9280-9291.
151. Toledo, E.M., Clombres, M. & Inestrosa, N.C. (2008) Wnt signaling in neuroprotection and stem cell differentiation. Prog. Neurobiol., 88, 281-296.
152. Vila, M., Jackson-Lewis, V., Guegan, C., Wu, D., Teismann, P., Choi, D.K., Tieu, K. & Przedborski, S. (2001) The role of glial cells in Parkinson's disease. Curr. Opin. Neurol., 14, 483-489.
153. Voskuhl, R.R., Peterson, R., Song, B., Ao, Y., Morales, L.B.J., Tiwari-Woodruff, S. & Sofroniew, M.V. (2009) Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci., 29, 11511-11522.
154. Wagner, J., Akerud, D.S., Castro, P.C., Holm, J.M., Canals, E.Y., Snyder, T., Perlmann, T. & Arenas, E. (1999) Induction of a midbrain dopaminergic phenotype in Nurr1-overexpressing neural stem cells by type 1 astrocytes. Nat. Biotechnol., 17, 653-659.
155. Wallenquist, U., Holmqvist, K., Hånell, A., Marklund, N., Hillered, L. & Forsberg-Nilsson, K. (2012) Ibuprofen attenuates the inflammatory response and allows formation of migratory neuroblasts from grafted stem cells after traumatic brain injury. Restor. Neurol. Neuros., 30, 9-19.
156. Wang, W., Yang, Y., Ying, C., Li, W., Ruan, H., Zhu, X., You, Y., Han, Y., Chen, R., Wang, Y. & Li, M. (2007) Inhibition of glycogen synthase kinase-3β protects dopaminergic neurons from MPTP toxicity. Neuropharmacology, 52, 1678-1684.
157. Warner, T.T. & Schapira, A.H.V. (2003) Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol., 53, S16-S25.
158. Wexler, E.M., Geschwind, D.H. & Palmer, T.D. (2008) Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol. Psychiatr., 13, 285-292.
159. Whitton, P.S. (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Brit. J. Pharmacol., 150, 963-976.
160. Willert, K. & Nusse, R. (2012) Wnt proteins. Cold Spring Harb. Perspect. Biol., 4, a007864.
161. Winner, B., Kohl, Z. & Gage, F.H. (2011) Neurodegenerative disease and adult neurogenesis. Eur. J. Neurosci., 33, 1139-1151.
162. Wu, D.C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.K., Ischiropoulos, H. & Przedborski, S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci., 22, 1763-1771.
163. Yu, J.M., Kim, J.H., Song, G.S. & Jung, J.S. (2006) Increase in proliferation and differentiation of neural progenitor cells isolated from postnatal and adult mice brain by Wnt-3a and Wnt-5a. Mol. Cell. Biochem., 288, 17-28.
164. Zhang, L., Yang, X., Yang, S. & Zhang, J. (2011) The Wnt/β-catenin signaling pathway in adult neurogenesis. Eur. J. Neurosci., 33, 1-8.
165. Zhang, Q.G., Wang, R., Khan, M., Maesh, V. & Brann, D.W. (2009) Role of Dikkopf-1 (Dkk1), an antagonist of the Wnt-β-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of Tau phosphorylation. J. Neurosci., 28, 8430-8441.
166. Zigmond, M.J., Cameron, J.L., Leak, K., Smejne, R.J. & Smith, A.D. (2009) Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency. Parkinsonism Relat. D., 15(S3), S42-S45.
167. Zigmond, M.J., Cameron, J.L., Hoffer, B.J. & Smeyne, R.J. (2012) Neurorestoration by physical exercise: moving forward. Parkinsonism Relat. D., 18(Suppl 1), S147-S150.